Eledon Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Eledon Pharmaceuticals, Inc. (ELDN) had Deferred Tax Assets, Operating Loss Carryforwards of $29.51 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-19
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $29.51M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $22.74M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $18.09M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.23M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $29.51M 10-K · filed 2026-03-19 | |
| 2024-12-31 | $22.74M 10-K · filed 2026-03-19 | |
| 2023-12-31 | $18.09M 10-K/A · filed 2025-08-14 | |
| 2022-12-31 | $15.23M 10-K/A · filed 2024-08-19 | |
| 2021-12-31 | $12.53M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $5.15M 10-K · filed 2022-03-24 | |
| 2019-12-31 | $9.95M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $7.13M 10-K · filed 2020-03-17 | |
| 2017-12-31 | $4.52M 10-K · filed 2019-03-28 | |
| 2016-12-31 | $2.93M 10-K · filed 2018-04-02 | $14.25M 10-K · filed 2017-03-03 |
| 2015-12-31 | $10.22M 10-K · filed 2017-03-03 | |
| 2014-12-31 | $6.29M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $3.99M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |